The impact of the combination of the GLP-1 analogue liraglutide (Victoza) and laparoscopic adjustable gastric banding (LAGB) on diabetes control.
Phase of Trial: Phase III
Latest Information Update: 06 Aug 2014
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GLIDE
- 17 Jul 2014 Status changed from recruiting to discontinued as reported by United Kingdom Clinical Research Network.
- 18 Oct 2013 Planned end date changed from 1 Sep 2015 to 1 Jun 2016 as reported by United Kingdom Clinical Research Network.
- 04 May 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.